Lantheus Holdings, Inc. (NASDAQ: LNTH) Stock Competitors & Peer Comparison
See LNTH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LNTH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LNTH | $100.90 | +0.22% | 6.6B | 16.93 | $5.95 | N/A |
| TAK | $17.42 | -0.37% | 55.4B | 12.52 | $1.39 | +3.62% |
| HLN | $9.79 | -1.51% | 43.2B | 18.28 | $0.54 | +1.80% |
| TEVA | $37.04 | +1.54% | 42.8B | 12.54 | $2.93 | N/A |
| VTRS | $16.25 | -0.16% | 18.7B | 6.39 | $2.52 | +2.98% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.60 | -0.59% | 11.1B | 20.91 | $1.06 | N/A |
| RDY | $12.42 | -0.24% | 10.3B | 20.30 | $0.61 | +0.67% |
| AMRX | $17.84 | +4.33% | 5.6B | 19.62 | $0.90 | N/A |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
LNTH vs TAK Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TAK has a market cap of 55.4B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TAK trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TAK's P/E ratio is 12.52. In terms of profitability, LNTH's ROE is +0.23%, compared to TAK's ROE of +0.02%. Regarding short-term risk, LNTH is less volatile compared to TAK. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TAK's competition here
Haleon plc (NYSE: HLN)
LNTH vs HLN Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, HLN has a market cap of 43.2B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while HLN trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas HLN's P/E ratio is 18.28. In terms of profitability, LNTH's ROE is +0.23%, compared to HLN's ROE of +0.17%. Regarding short-term risk, LNTH is less volatile compared to HLN. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check HLN's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
LNTH vs TEVA Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TEVA has a market cap of 42.8B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TEVA trades at $37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TEVA's P/E ratio is 12.54. In terms of profitability, LNTH's ROE is +0.23%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, LNTH is less volatile compared to TEVA. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TEVA's competition here
Viatris Inc. (NASDAQ: VTRS)
LNTH vs VTRS Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, VTRS has a market cap of 18.7B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while VTRS trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas VTRS's P/E ratio is 6.39. In terms of profitability, LNTH's ROE is +0.23%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, LNTH is less volatile compared to VTRS. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
LNTH vs ITCI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ITCI's P/E ratio is -180.64. In terms of profitability, LNTH's ROE is +0.23%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, LNTH is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
LNTH vs CTLT Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CTLT's P/E ratio is -27.84. In terms of profitability, LNTH's ROE is +0.23%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, LNTH is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
LNTH vs ELAN Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ELAN has a market cap of 11.1B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ELAN trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ELAN's P/E ratio is 20.91. In terms of profitability, LNTH's ROE is +0.23%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, LNTH is less volatile compared to ELAN. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
LNTH vs RDY Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, RDY has a market cap of 10.3B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while RDY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas RDY's P/E ratio is 20.30. In terms of profitability, LNTH's ROE is +0.23%, compared to RDY's ROE of +0.09%. Regarding short-term risk, LNTH is less volatile compared to RDY. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check RDY's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
LNTH vs AMRX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AMRX has a market cap of 5.6B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AMRX trades at $17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AMRX's P/E ratio is 19.62. In terms of profitability, LNTH's ROE is +0.23%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, LNTH is less volatile compared to AMRX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
LNTH vs INDV Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while INDV trades at $38.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas INDV's P/E ratio is 10.61. In terms of profitability, LNTH's ROE is +0.23%, compared to INDV's ROE of -2.16%. Regarding short-term risk, LNTH is less volatile compared to INDV. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check INDV's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
LNTH vs SUPN Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SUPN trades at $47.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SUPN's P/E ratio is 15.64. In terms of profitability, LNTH's ROE is +0.23%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, LNTH is less volatile compared to SUPN. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SUPN's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
LNTH vs RGC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, RGC has a market cap of 2.5B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while RGC trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas RGC's P/E ratio is -356.34. In terms of profitability, LNTH's ROE is +0.23%, compared to RGC's ROE of -2.32%. Regarding short-term risk, LNTH is less volatile compared to RGC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check RGC's competition here
Bausch Health Companies Inc. (NYSE: BHC)
LNTH vs BHC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while BHC trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas BHC's P/E ratio is 1.58. In terms of profitability, LNTH's ROE is +0.23%, compared to BHC's ROE of +0.89%. Regarding short-term risk, LNTH is less volatile compared to BHC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check BHC's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
LNTH vs DCPH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas DCPH's P/E ratio is -11.58. In terms of profitability, LNTH's ROE is +0.23%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, LNTH is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check DCPH's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
LNTH vs HCM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, HCM has a market cap of 2.1B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while HCM trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas HCM's P/E ratio is 4.59. In terms of profitability, LNTH's ROE is +0.23%, compared to HCM's ROE of +0.01%. Regarding short-term risk, LNTH is less volatile compared to HCM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check HCM's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
LNTH vs AVDL Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, LNTH's ROE is +0.23%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, LNTH is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check AVDL's competition here
Embecta Corp. (NASDAQ: EMBCV)
LNTH vs EMBCV Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas EMBCV's P/E ratio is N/A. In terms of profitability, LNTH's ROE is +0.23%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, LNTH is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check EMBCV's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
LNTH vs DVAX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas DVAX's P/E ratio is -41.89. In terms of profitability, LNTH's ROE is +0.23%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, LNTH is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check DVAX's competition here
Perrigo Company plc (NYSE: PRGO)
LNTH vs PRGO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PRGO trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PRGO's P/E ratio is 5.07. In terms of profitability, LNTH's ROE is +0.23%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, LNTH is less volatile compared to PRGO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check PRGO's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
LNTH vs ANIP Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ANIP trades at $75.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ANIP's P/E ratio is 9.14. In terms of profitability, LNTH's ROE is +0.23%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, LNTH is less volatile compared to ANIP. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ANIP's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
LNTH vs TARO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TARO's P/E ratio is 30.05. In terms of profitability, LNTH's ROE is +0.23%, compared to TARO's ROE of +0.03%. Regarding short-term risk, LNTH is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check TARO's competition here
Harrow Health, Inc. (NASDAQ: HROW)
LNTH vs HROW Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while HROW trades at $39.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas HROW's P/E ratio is 437.33. In terms of profitability, LNTH's ROE is +0.23%, compared to HROW's ROE of -1.04%. Regarding short-term risk, LNTH is less volatile compared to HROW. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check HROW's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
LNTH vs PAHC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PAHC trades at $34.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PAHC's P/E ratio is 11.54. In terms of profitability, LNTH's ROE is +0.23%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, LNTH is less volatile compared to PAHC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check PAHC's competition here
Alvotech (NASDAQ: ALVO)
LNTH vs ALVO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ALVO has a market cap of 1.4B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ALVO trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ALVO's P/E ratio is -11.79. In terms of profitability, LNTH's ROE is +0.23%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, LNTH is less volatile compared to ALVO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ALVO's competition here
Cronos Group Inc. (NASDAQ: CRON)
LNTH vs CRON Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CRON trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CRON's P/E ratio is 30.10. In terms of profitability, LNTH's ROE is +0.23%, compared to CRON's ROE of +0.06%. Regarding short-term risk, LNTH is less volatile compared to CRON. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check CRON's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
LNTH vs ETON Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ETON has a market cap of 1.1B. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ETON trades at $42.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ETON's P/E ratio is -594.00. In terms of profitability, LNTH's ROE is +0.23%, compared to ETON's ROE of -0.06%. Regarding short-term risk, LNTH is less volatile compared to ETON. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ETON's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
LNTH vs PCRX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PCRX has a market cap of 932.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PCRX trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PCRX's P/E ratio is 9.12. In terms of profitability, LNTH's ROE is +0.23%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, LNTH is less volatile compared to PCRX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check PCRX's competition here
PetIQ, Inc. (NASDAQ: PETQ)
LNTH vs PETQ Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PETQ's P/E ratio is 83.73. In terms of profitability, LNTH's ROE is +0.23%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, LNTH is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check PETQ's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
LNTH vs AMPH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AMPH has a market cap of 881M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AMPH trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AMPH's P/E ratio is 6.82. In terms of profitability, LNTH's ROE is +0.23%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, LNTH is less volatile compared to AMPH. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check AMPH's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
LNTH vs COLL Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, COLL has a market cap of 842.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while COLL trades at $28.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas COLL's P/E ratio is 3.26. In terms of profitability, LNTH's ROE is +0.23%, compared to COLL's ROE of +0.16%. Regarding short-term risk, LNTH is less volatile compared to COLL. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check COLL's competition here
Evotec SE (NASDAQ: EVO)
LNTH vs EVO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, EVO has a market cap of 778M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while EVO trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas EVO's P/E ratio is -3.09. In terms of profitability, LNTH's ROE is +0.23%, compared to EVO's ROE of -0.24%. Regarding short-term risk, LNTH is less volatile compared to EVO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check EVO's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
LNTH vs IRWD Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while IRWD trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas IRWD's P/E ratio is 5.54. In terms of profitability, LNTH's ROE is +0.23%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, LNTH is less volatile compared to IRWD. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check IRWD's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
LNTH vs BDSI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas BDSI's P/E ratio is 6.82. In terms of profitability, LNTH's ROE is +0.23%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, LNTH is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check BDSI's competition here
Evolus, Inc. (NASDAQ: EOLS)
LNTH vs EOLS Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, EOLS has a market cap of 534.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while EOLS trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas EOLS's P/E ratio is -25.71. In terms of profitability, LNTH's ROE is +0.23%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, LNTH is less volatile compared to EOLS. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check EOLS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
LNTH vs AQST Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AQST has a market cap of 530.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AQST trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AQST's P/E ratio is -6.93. In terms of profitability, LNTH's ROE is +0.23%, compared to AQST's ROE of +2.44%. Regarding short-term risk, LNTH is less volatile compared to AQST. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check AQST's competition here
Tilray Brands, Inc. (NASDAQ: TLRY)
LNTH vs TLRY Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TLRY has a market cap of 523.4M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TLRY trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TLRY's P/E ratio is -4.32. In terms of profitability, LNTH's ROE is +0.23%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, LNTH is less volatile compared to TLRY. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TLRY's competition here
Canopy Growth Corporation (NASDAQ: CGC)
LNTH vs CGC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CGC has a market cap of 432.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CGC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CGC's P/E ratio is -0.62. In terms of profitability, LNTH's ROE is +0.23%, compared to CGC's ROE of -0.33%. Regarding short-term risk, LNTH is less volatile compared to CGC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check CGC's competition here
Kamada Ltd. (NASDAQ: KMDA)
LNTH vs KMDA Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, KMDA has a market cap of 396.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while KMDA trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas KMDA's P/E ratio is 19.66. In terms of profitability, LNTH's ROE is +0.23%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, LNTH is less volatile compared to KMDA. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check KMDA's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
LNTH vs TKNO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TKNO has a market cap of 396.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TKNO trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TKNO's P/E ratio is -23.84. In terms of profitability, LNTH's ROE is +0.23%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, LNTH is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TKNO's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
LNTH vs ALIM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ALIM's P/E ratio is 5.28. In terms of profitability, LNTH's ROE is +0.23%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, LNTH is less volatile compared to ALIM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ALIM's competition here
Embecta Corp. (NASDAQ: EMBC)
LNTH vs EMBC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, EMBC has a market cap of 281.8M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while EMBC trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas EMBC's P/E ratio is 1.83. In terms of profitability, LNTH's ROE is +0.23%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, LNTH is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check EMBC's competition here
Landec Corporation (NASDAQ: LNDC)
LNTH vs LNDC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas LNDC's P/E ratio is -4.04. In terms of profitability, LNTH's ROE is +0.23%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, LNTH is less volatile compared to LNDC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check LNDC's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
LNTH vs ACB Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ACB has a market cap of 236.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ACB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ACB's P/E ratio is -7.80. In terms of profitability, LNTH's ROE is +0.23%, compared to ACB's ROE of -0.21%. Regarding short-term risk, LNTH is less volatile compared to ACB. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ACB's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
LNTH vs ORGO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ORGO has a market cap of 232.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ORGO trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ORGO's P/E ratio is 60.33. In terms of profitability, LNTH's ROE is +0.23%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, LNTH is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ORGO's competition here
Shineco, Inc. (NASDAQ: TYHT)
LNTH vs TYHT Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TYHT's P/E ratio is -1.61. In terms of profitability, LNTH's ROE is +0.23%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, LNTH is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TYHT's competition here
SIGA Technologies, Inc. (NASDAQ: SIGA)
LNTH vs SIGA Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SIGA has a market cap of 205.8M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SIGA trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SIGA's P/E ratio is 10.63. In terms of profitability, LNTH's ROE is +0.23%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, LNTH is less volatile compared to SIGA. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SIGA's competition here
Organigram Global Inc. (NASDAQ: OGI)
LNTH vs OGI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, OGI has a market cap of 181.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while OGI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas OGI's P/E ratio is -4.96. In terms of profitability, LNTH's ROE is +0.23%, compared to OGI's ROE of -0.07%. Regarding short-term risk, LNTH is less volatile compared to OGI. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check OGI's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
LNTH vs LFCR Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, LFCR has a market cap of 178.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while LFCR trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas LFCR's P/E ratio is -4.46. In terms of profitability, LNTH's ROE is +0.23%, compared to LFCR's ROE of -2.51%. Regarding short-term risk, LNTH is less volatile compared to LFCR. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check LFCR's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
LNTH vs REPH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas REPH's P/E ratio is -8.04. In terms of profitability, LNTH's ROE is +0.23%, compared to REPH's ROE of -0.22%. Regarding short-term risk, LNTH is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check REPH's competition here
Journey Medical Corporation (NASDAQ: DERM)
LNTH vs DERM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, DERM has a market cap of 177M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while DERM trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas DERM's P/E ratio is -17.38. In terms of profitability, LNTH's ROE is +0.23%, compared to DERM's ROE of -0.36%. Regarding short-term risk, LNTH is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check DERM's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
LNTH vs CRDL Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CRDL has a market cap of 175.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CRDL trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CRDL's P/E ratio is -5.41. In terms of profitability, LNTH's ROE is +0.23%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, LNTH is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check CRDL's competition here
Theratechnologies Inc. (NASDAQ: THTX)
LNTH vs THTX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas THTX's P/E ratio is -28.83. In terms of profitability, LNTH's ROE is +0.23%, compared to THTX's ROE of +0.17%. Regarding short-term risk, LNTH is less volatile compared to THTX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
LNTH vs ASRT Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ASRT's P/E ratio is -7.10. In terms of profitability, LNTH's ROE is +0.23%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, LNTH is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check ASRT's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
LNTH vs CPIX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CPIX has a market cap of 119.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CPIX trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CPIX's P/E ratio is -19.90. In terms of profitability, LNTH's ROE is +0.23%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, LNTH is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check CPIX's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
LNTH vs SCTL Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SCTL's P/E ratio is -7.86. In terms of profitability, LNTH's ROE is +0.23%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, LNTH is less volatile compared to SCTL. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SCTL's competition here
BGM Group Ltd. (NASDAQ: BGM)
LNTH vs BGM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, BGM has a market cap of 111.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while BGM trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas BGM's P/E ratio is -1.01. In terms of profitability, LNTH's ROE is +0.23%, compared to BGM's ROE of -0.07%. Regarding short-term risk, LNTH is less volatile compared to BGM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check BGM's competition here
Procaps Group S.A. (NASDAQ: PROC)
LNTH vs PROC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PROC's P/E ratio is 1.53. In terms of profitability, LNTH's ROE is +0.23%, compared to PROC's ROE of -2.22%. Regarding short-term risk, LNTH is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check PROC's competition here
OptiNose, Inc. (NASDAQ: OPTN)
LNTH vs OPTN Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas OPTN's P/E ratio is -4.42. In terms of profitability, LNTH's ROE is +0.23%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, LNTH is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
LNTH vs ZOM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ZOM's P/E ratio is -1.62. In terms of profitability, LNTH's ROE is +0.23%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, LNTH is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ZOM's competition here
Upexi, Inc. (NASDAQ: GRVI)
LNTH vs GRVI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas GRVI's P/E ratio is 26.05. In terms of profitability, LNTH's ROE is +0.23%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, LNTH is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check GRVI's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
LNTH vs ZYBT Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ZYBT has a market cap of 73.5M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ZYBT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ZYBT's P/E ratio is -7.05. In terms of profitability, LNTH's ROE is +0.23%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, LNTH is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ZYBT's competition here
Talphera, Inc. (NASDAQ: TLPH)
LNTH vs TLPH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TLPH has a market cap of 72.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TLPH trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TLPH's P/E ratio is -4.52. In terms of profitability, LNTH's ROE is +0.23%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, LNTH is less volatile compared to TLPH. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TLPH's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
LNTH vs ZYNE Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, LNTH's ROE is +0.23%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, LNTH is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
LNTH vs SSIC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SSIC's P/E ratio is 11.93. In terms of profitability, LNTH's ROE is +0.23%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, LNTH is less volatile compared to SSIC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SSIC's competition here
The Valens Company Inc. (NASDAQ: VLNS)
LNTH vs VLNS Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas VLNS's P/E ratio is -1.03. In terms of profitability, LNTH's ROE is +0.23%, compared to VLNS's ROE of N/A. Regarding short-term risk, LNTH is less volatile compared to VLNS. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check VLNS's competition here
DURECT Corporation (NASDAQ: DRRX)
LNTH vs DRRX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas DRRX's P/E ratio is -4.44. In terms of profitability, LNTH's ROE is +0.23%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, LNTH is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check DRRX's competition here
InterCure Ltd. (NASDAQ: INCR)
LNTH vs INCR Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, INCR has a market cap of 57.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while INCR trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas INCR's P/E ratio is -2.23. In terms of profitability, LNTH's ROE is +0.23%, compared to INCR's ROE of -0.09%. Regarding short-term risk, LNTH is less volatile compared to INCR. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check INCR's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
LNTH vs JUPW Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas JUPW's P/E ratio is -2.41. In terms of profitability, LNTH's ROE is +0.23%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, LNTH is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check JUPW's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
LNTH vs CPHI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CPHI has a market cap of 44.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CPHI trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CPHI's P/E ratio is -1.72. In terms of profitability, LNTH's ROE is +0.23%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, LNTH is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check CPHI's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
LNTH vs QLI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas QLI's P/E ratio is -4.92. In terms of profitability, LNTH's ROE is +0.23%, compared to QLI's ROE of -0.16%. Regarding short-term risk, LNTH is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check QLI's competition here
HEXO Corp. (NASDAQ: HEXO)
LNTH vs HEXO Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas HEXO's P/E ratio is -0.26. In terms of profitability, LNTH's ROE is +0.23%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, LNTH is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check HEXO's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
LNTH vs RMTI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, RMTI has a market cap of 30.8M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while RMTI trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas RMTI's P/E ratio is -7.42. In terms of profitability, LNTH's ROE is +0.23%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, LNTH is less volatile compared to RMTI. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check RMTI's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
LNTH vs AYTU Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AYTU trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AYTU's P/E ratio is -1.23. In terms of profitability, LNTH's ROE is +0.23%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, LNTH is less volatile compared to AYTU. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check AYTU's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
LNTH vs TXMD Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, TXMD has a market cap of 24.1M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while TXMD trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas TXMD's P/E ratio is 105.96. In terms of profitability, LNTH's ROE is +0.23%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, LNTH is less volatile compared to TXMD. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
LNTH vs CYTH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CYTH's P/E ratio is -0.80. In terms of profitability, LNTH's ROE is +0.23%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, LNTH is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check CYTH's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
LNTH vs EVOK Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas EVOK's P/E ratio is -7.97. In terms of profitability, LNTH's ROE is +0.23%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, LNTH is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check EVOK's competition here
Optimi Health Corp. (NASDAQ: OPTH)
LNTH vs OPTH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, OPTH has a market cap of 15.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while OPTH trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas OPTH's P/E ratio is -17.38. In terms of profitability, LNTH's ROE is +0.23%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, LNTH is less volatile compared to OPTH. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
LNTH vs ACRX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ACRX's P/E ratio is -0.31. In terms of profitability, LNTH's ROE is +0.23%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, LNTH is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ACRX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
LNTH vs BFRIW Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, BFRIW has a market cap of 13.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while BFRIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, LNTH's ROE is +0.23%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, LNTH is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
LNTH vs COSM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, COSM has a market cap of 11.7M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while COSM trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas COSM's P/E ratio is -0.29. In terms of profitability, LNTH's ROE is +0.23%, compared to COSM's ROE of -0.96%. Regarding short-term risk, LNTH is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check COSM's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
LNTH vs AGRX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas AGRX's P/E ratio is -0.89. In terms of profitability, LNTH's ROE is +0.23%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, LNTH is less volatile compared to AGRX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
LNTH vs NLTX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas NLTX's P/E ratio is -0.28. In terms of profitability, LNTH's ROE is +0.23%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, LNTH is less volatile compared to NLTX. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
LNTH vs LCI Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas LCI's P/E ratio is -0.04. In terms of profitability, LNTH's ROE is +0.23%, compared to LCI's ROE of +1.66%. Regarding short-term risk, LNTH is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
LNTH vs ADMP Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ADMP's P/E ratio is -0.08. In terms of profitability, LNTH's ROE is +0.23%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, LNTH is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check ADMP's competition here
cbdMD, Inc. (AMEX: YCBD)
LNTH vs YCBD Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, YCBD has a market cap of 6.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while YCBD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas YCBD's P/E ratio is -1.49. In terms of profitability, LNTH's ROE is +0.23%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, LNTH is less volatile compared to YCBD. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check YCBD's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
LNTH vs GELS Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while GELS trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas GELS's P/E ratio is -1.14. In terms of profitability, LNTH's ROE is +0.23%, compared to GELS's ROE of -0.25%. Regarding short-term risk, LNTH is less volatile compared to GELS. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check GELS's competition here
Mallinckrodt plc (AMEX: MNK)
LNTH vs MNK Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas MNK's P/E ratio is -0.44. In terms of profitability, LNTH's ROE is +0.23%, compared to MNK's ROE of -0.36%. Regarding short-term risk, LNTH is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check MNK's competition here
Flora Growth Corp. (NASDAQ: FLGC)
LNTH vs FLGC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas FLGC's P/E ratio is -0.19. In terms of profitability, LNTH's ROE is +0.23%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, LNTH is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check FLGC's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
LNTH vs UPC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, UPC has a market cap of 3.8M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while UPC trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas UPC's P/E ratio is -0.75. In terms of profitability, LNTH's ROE is +0.23%, compared to UPC's ROE of -0.03%. Regarding short-term risk, LNTH is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check UPC's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
LNTH vs SBFM Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SBFM trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SBFM's P/E ratio is -0.20. In terms of profitability, LNTH's ROE is +0.23%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, LNTH is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SBFM's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
LNTH vs PLXP Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PLXP's P/E ratio is -0.22. In terms of profitability, LNTH's ROE is +0.23%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, LNTH is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check PLXP's competition here
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH)
LNTH vs SHPH Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SHPH has a market cap of 2.5M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SHPH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SHPH's P/E ratio is -0.20. In terms of profitability, LNTH's ROE is +0.23%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, LNTH is less volatile compared to SHPH. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SHPH's competition here
Athenex, Inc. (NASDAQ: ATNX)
LNTH vs ATNX Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas ATNX's P/E ratio is -0.02. In terms of profitability, LNTH's ROE is +0.23%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, LNTH is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check ATNX's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
LNTH vs SNOA Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SNOA has a market cap of 2.3M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SNOA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SNOA's P/E ratio is -1.16. In terms of profitability, LNTH's ROE is +0.23%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, LNTH is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SNOA's competition here
Procaps Group, S.A. (NASDAQ: PROCW)
LNTH vs PROCW Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas PROCW's P/E ratio is N/A. In terms of profitability, LNTH's ROE is +0.23%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, LNTH is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check PROCW's competition here
RedHill Biopharma Ltd. (NASDAQ: RDHL)
LNTH vs RDHL Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while RDHL trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas RDHL's P/E ratio is 0.12. In terms of profitability, LNTH's ROE is +0.23%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, LNTH is less volatile compared to RDHL. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check RDHL's competition here
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
LNTH vs SXTC Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, SXTC has a market cap of 1.8M. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while SXTC trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas SXTC's P/E ratio is 1.18. In terms of profitability, LNTH's ROE is +0.23%, compared to SXTC's ROE of -0.31%. Regarding short-term risk, LNTH is less volatile compared to SXTC. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check SXTC's competition here
cbdMD, Inc. (AMEX: YCBD-PA)
LNTH vs YCBD-PA Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while YCBD-PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, LNTH's ROE is +0.23%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, LNTH is less volatile compared to YCBD-PA. This indicates lower risk in terms of short-term price fluctuations for LNTH.Check YCBD-PA's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTHW)
LNTH vs CYTHW Comparison August 2026
Lantheus Holdings, Inc. (NASDAQ: LNTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LNTH stands at 6.6B. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, LNTH is priced at $100.90 on the NASDAQ, while CYTHW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LNTH currently has a P/E ratio of 16.93, whereas CYTHW's P/E ratio is N/A. In terms of profitability, LNTH's ROE is +0.23%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, LNTH is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for LNTH.Check CYTHW's competition here